Sikirić P, Rotkvić I, Mise S, Krizanac S, Gjuris V, Jukić J, Suchanek E, Petek M, Udovicić I, Kalogjera L
Department of Pharmacology, Medical Faculty University of Zagreb, Yugoslavia.
Eur J Pharmacol. 1988 Dec 6;158(1-2):61-7. doi: 10.1016/0014-2999(88)90253-1.
Dopamine agents (saline in control groups) were coadministered with indomethacin by either single or repeated application. The ulcerogenic effect (erosions and/or ulcers) of repeated given indomethacin on gastric mucosa differed clearly from that on intestinal mucosa. The effect on intestinal mucosa was markedly greater than after a single dose. The effects of dopamine agents appeared to be more consistent. Domperidone and haloperidol, given as single or repeated doses, strongly aggravated both the gastric and intestinal lesions. Bromocriptine and amantadine had a protective effect. The adverse effects of both dopamine antagonists (increased after repeated administration) were strongly inhibited by the simultaneous administration of either bromocriptine or amantadine. The involvement of the dopamine system (central or peripheral) in the mechanisms that maintain gastric (probably related to cytoprotection also) and intestinal mucosa integrity is therefore suggested.
多巴胺制剂(对照组为生理盐水)与吲哚美辛通过单次或重复给药联合使用。重复给予吲哚美辛对胃黏膜的致溃疡作用(糜烂和/或溃疡)与对肠黏膜的作用明显不同。对肠黏膜的作用明显大于单次给药后。多巴胺制剂的作用似乎更具一致性。多潘立酮和氟哌啶醇,单次或重复给药,均强烈加重胃和肠道损伤。溴隐亭和金刚烷胺具有保护作用。同时给予溴隐亭或金刚烷胺可强烈抑制两种多巴胺拮抗剂的不良反应(重复给药后增加)。因此提示多巴胺系统(中枢或外周)参与维持胃(可能也与细胞保护有关)和肠黏膜完整性的机制。